Cimzia Risks Linked To Cancer
September 29, 2008 · Filed Under Cancer Treatment · Comment
The TNF blocker known as Cimzia was recently linked to the development of cancerous cells among patients. Cimzia, which treats autoimmune disorders, has been associated with the condition specifically among young adults and children. Read more
Cimzia Effective With Stable Dosing In Crohn’s Disease
UCB announced today that data presented at Digestive Disease Week reaffirm the long-term, sustainable efficacy and safety of Cimzia (certolizumab pegol) at stable doses in treating patients with moderate to severe Crohn’s disease. Read more

